packageTerazosin

terazosin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Terazosin is an alpha-blocker used to treat high blood pressure and urinary problems caused by an enlarged prostate, such as difficulty passing urine. It is an approved medicine and is used fairly widely, mainly for benign prostatic enlargement.

Summary written by glm-5.3-flash from Wikidata Q280786 and the WHO ATC classification; not checked by a person.

name:terazosin
ATC codes:G04CA03
DrugBank:DB01162
PubChem CID:5401
ChEBI:9445
Wikidata:Q280786
formula:C19H25N5O4
molar mass:387.44 g/mol (PubChem CID 5401)
logP:1.4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown